Neuraxis, INC (NRXS) stock
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.87+0.26 (+5.64%)
Close on Nov 18, 2026Market cap $61.16MP/E –Yield –
Neuraxis total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Neuraxis's total debt was $42.73K at Jun 30, 2026. For fiscal 2025 it was $148.29K, down 3.8% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $148.29K | -3.8% |
| FY2024 | Dec 31, 2024 | $154.15K | +4.1% |
| FY2023 | Dec 31, 2023 | $148.06K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $42.73K | -64.8% |
| Q1 FY2026 | Mar 31, 2026 | $100.74K | +19.5% |
| Q4 FY2025 | Dec 31, 2025 | $148.29K | -3.8% |
| Q3 FY2025 | Sep 30, 2025 | $195.66K | +32.5% |
| Q2 FY2025 | Jun 30, 2025 | $121.43K | -97.5% |
| Q1 FY2025 | Mar 31, 2025 | $84.31K | -94.0% |
| Q4 FY2024 | Dec 31, 2024 | $154.15K | +4.1% |
| Q3 FY2024 | Sep 30, 2024 | $147.69K | -23.9% |
| Q2 FY2024 | Jun 30, 2024 | $4.77M | +209.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.40M | – |
| Q4 FY2023 | Dec 31, 2023 | $148.06K | – |
| Q3 FY2023 | Sep 30, 2023 | $194.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $1.54M | – |
See a number that looks wrong?